DK3427723T3 - Rna-formulering til immunterapi - Google Patents

Rna-formulering til immunterapi Download PDF

Info

Publication number
DK3427723T3
DK3427723T3 DK18171522.8T DK18171522T DK3427723T3 DK 3427723 T3 DK3427723 T3 DK 3427723T3 DK 18171522 T DK18171522 T DK 18171522T DK 3427723 T3 DK3427723 T3 DK 3427723T3
Authority
DK
Denmark
Prior art keywords
immunteraphy
rna formulation
rna
formulation
Prior art date
Application number
DK18171522.8T
Other languages
English (en)
Inventor
Ugur Sahin
Heinrich Haas
Sebastian Kreiter
Mustafa Diken
Daniel Fritz
Martin Meng
Lena Mareen Kranz
Kerstin Reuter
Original Assignee
Biontech Rna Pharmaceuticals Gmbh
Tron Translationale Onkologie An Der Univ Der Johannes Gutenberg Univ Mainz Gemeinnuetzige Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/001319 external-priority patent/WO2013143555A1/en
Application filed by Biontech Rna Pharmaceuticals Gmbh, Tron Translationale Onkologie An Der Univ Der Johannes Gutenberg Univ Mainz Gemeinnuetzige Gmbh filed Critical Biontech Rna Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK3427723T3 publication Critical patent/DK3427723T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
DK18171522.8T 2012-03-26 2013-03-25 Rna-formulering til immunterapi DK3427723T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/001319 WO2013143555A1 (en) 2012-03-26 2012-03-26 Rna formulation for immunotherapy
EP13713356.7A EP2830593B1 (en) 2012-03-26 2013-03-25 Rna formulation for immunotherapy

Publications (1)

Publication Number Publication Date
DK3427723T3 true DK3427723T3 (da) 2020-10-12

Family

ID=52114006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18171522.8T DK3427723T3 (da) 2012-03-26 2013-03-25 Rna-formulering til immunterapi

Country Status (8)

Country Link
EP (3) EP2830593B1 (da)
CY (2) CY1121697T1 (da)
DK (1) DK3427723T3 (da)
HR (1) HRP20190607T1 (da)
ME (1) ME03367B (da)
PL (2) PL3427723T3 (da)
RS (1) RS58794B1 (da)
SI (1) SI2830593T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013143555A1 (en) 2012-03-26 2013-10-03 Biontech Ag Rna formulation for immunotherapy
MX2020003413A (es) 2017-10-20 2020-07-20 BioNTech SE Preparacion y almacenamiento de formulaciones liposomales de arn adecuadas para terapia.
WO2020200472A1 (en) * 2019-04-05 2020-10-08 Biontech Rna Pharmaceuticals Gmbh Preparation and storage of liposomal rna formulations suitable for therapy
CN113225313A (zh) * 2021-03-26 2021-08-06 大唐三门峡发电有限责任公司 一种用于dcs系统的信息安全防护系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US20090004213A1 (en) 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
WO2010037408A1 (en) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
DE102008061522A1 (de) * 2008-12-10 2010-06-17 Biontech Ag Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
US20110300205A1 (en) * 2009-07-06 2011-12-08 Novartis Ag Self replicating rna molecules and uses thereof
BR112013000244A2 (pt) * 2010-07-06 2016-05-17 Novartis Ag lipossomas com lipídeos apresentando pka vantajoso para administração de rna
WO2013113325A1 (en) * 2012-01-31 2013-08-08 Curevac Gmbh Negatively charged nucleic acid comprising complexes for immunostimulation

Also Published As

Publication number Publication date
EP2830593A1 (en) 2015-02-04
PL2830593T3 (pl) 2019-08-30
EP2830593B1 (en) 2019-02-27
SI2830593T1 (sl) 2019-07-31
RS58794B1 (sr) 2019-07-31
EP3777840A1 (en) 2021-02-17
HRP20190607T1 (hr) 2019-07-12
CY1123453T1 (el) 2022-03-24
CY1121697T1 (el) 2020-07-31
PL3427723T3 (pl) 2021-01-11
EP3427723A1 (en) 2019-01-16
EP3427723B1 (en) 2020-08-05
ME03367B (me) 2019-10-20

Similar Documents

Publication Publication Date Title
DK2858671T3 (da) Antistofformulering
DK2859055T3 (da) Polymercoatings
DK2825087T3 (da) Otoscanner
DK2890397T3 (da) Antiprolactinreceptor-antistofformulering
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
BR112014028602A2 (pt) formulação líquida.
BR112014032798A2 (pt) composição
DK2800476T3 (da) Fremgangsmåde til fodring
DK2825157T3 (da) Aminosyrelipider
BR112014000015A2 (pt) formulação
DK2897594T3 (da) Farmaceutisk sammensætning
DK2868318T4 (da) Injicerbar formulering
DK2849760T3 (da) Fremgangsmåder til oligonukleotid-chelatkompleks
CL2014003283A1 (es) Formulación farmacéutica.
DK2831122T3 (da) Anthocyanidin-kompleks
UA25626S (uk) Печиво
DE112012006214T8 (de) Wulstringwickler
FR2988427B1 (fr) Plate-forme inter-aubes
BR112014032712A2 (pt) composição
FR2988426B1 (fr) Plate-forme inter-aubes
DE112012005566T8 (de) Seltenerdnanoverbundmagnet
DK3427723T3 (da) Rna-formulering til immunterapi